Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1995
05/11/1995CA2135440A1 Heterocyclic compounds, their production and use
05/10/1995EP0652228A1 Urethanes and ureas that induce cytokine production
05/10/1995EP0652226A1 Process of preparing etoposide phosphate and etoposide
05/10/1995EP0652218A1 Heterocyclic compounds, their production and use
05/10/1995EP0652217A1 N-substituted imidazole derivatives
05/10/1995EP0652214A1 N-Aryl-2-cyano-3-hydroxy propenamide derivatives, a method for their preparation, their use as medicaments and pharmaceutical compositions containing them
05/10/1995EP0652208A1 Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity
05/10/1995EP0652012A1 Combination of sugars with animo acids and other drugs
05/10/1995EP0652011A1 Prophylactic and remedy for viral diseases in respiratory tract
05/10/1995EP0652010A1 Use of alphatocopherol acetate or a derivative for the preparation of cosmetic, dermatalogical or pharmaceutical compositions with anti radical activity
05/10/1995EP0652009A1 Identification and use of protease inhibitors
05/10/1995EP0652007A1 Use of 2-phenyl-3-aryl-dihydrobenzopyrans for inhibiting bone loss
05/10/1995EP0652006A1 Use of 2-phenyl-3-aryl-dihychobenzopyrans for lowering serum cholesterol
05/10/1995EP0652005A1 Methods for inhibiting endometriosis
05/10/1995EP0652004A1 Methods for treating resistant neoplasms
05/10/1995EP0652003A1 Methods for inhibiting smooth muscle cell proliferation and restinosis
05/10/1995EP0652002A1 Methods for inhibiting cartilage degradation
05/10/1995EP0652001A1 Methods for treating per-menopausal syndrome
05/10/1995EP0652000A1 Methods for inhibiting angiogenisis and angiogenic diseases
05/10/1995EP0651999A1 Methods of inhibiting uterine fibrosis
05/10/1995EP0651998A1 Methods for inhibiting bone loss
05/10/1995EP0651992A1 Use of soaps as antiageing agents in cosmetic and/or dermatological compositions
05/10/1995EP0651816A1 Blood levels of cck peptides relative to panic disorder treatment
05/10/1995EP0651807A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
05/10/1995EP0651805A1 Method of intracellular binding of target molecules
05/10/1995EP0651798A1 Target antigens of transmission blocking antibodies for malaria parsites
05/10/1995EP0651796A1 Unstabilising viral quasi-species distributions for avoiding resistance phenomena
05/10/1995EP0651759A1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
05/10/1995EP0651757A1 Novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds.
05/10/1995EP0651756A1 Tricyclic defem sulphones as elastase inhibitors
05/10/1995EP0651755A1 Cephalosporins and 1-carba-1-dethia cephalosporins
05/10/1995EP0651753A1 Pyridonecarboxylic acid derivatives and processes for preparing the same
05/10/1995EP0651750A1 Tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents
05/10/1995EP0651749A1 Imidazole, triazole and tetrazole derivatives
05/10/1995EP0651746A1 Drugs that enhance synaptic responses mediated by ampa receptors
05/10/1995EP0651745A1 New pyridine derivatives as leukcotriene b 4? antagonists
05/10/1995EP0651744A1 4-(4-fluorophenylmethyl)-piperidines having sigma and d2-receptor affinity
05/10/1995EP0651743A1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors
05/10/1995EP0651740A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours
05/10/1995EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors
05/10/1995EP0651735A1 Pharmacologically active alpha-(tertiary-aminomethyl)-phenylmethanol derivatives
05/10/1995EP0651654A1 Lysozyme dimer and compositions containing the same
05/10/1995EP0651646A1 Therapeutic conjugates of toxins and drugs
05/10/1995EP0651645A1 Medicament for inhibiting neutrophil elastase and cathepsin g
05/10/1995EP0651644A1 Ovulation inhibitor for hormonal contraception
05/10/1995EP0651643A1 17-ALKYLKETONE STEROIDS USEFUL AS 5-$g(a)-REDUCTASE INHIBITORS
05/10/1995EP0651642A1 Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
05/10/1995EP0651641A1 Novel bioactive compositions, preparation and use thereof
05/10/1995EP0651640A1 Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris
05/10/1995EP0651639A1 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
05/10/1995EP0651638A1 Pharmaceutical composition and method of treatment for serotonin depletion illness
05/10/1995EP0651637A1 Control of wound scar production with calcium antagonists alone or in a combination with a steroid
05/10/1995EP0651636A1 Chemotherapy for cancer
05/10/1995EP0548261B1 Spontaneously dispersible concentrate containing a sterol ester and sterol phosphatide respectively
05/10/1995EP0542837B1 Propylamine derivatives
05/10/1995EP0532706B1 REDUCTION OF CARDIOVASCULAR VESSEL OCCLUSIONS WITH ASCORBATE AND LIPOPROTEIN (a) BINDING INHIBITORS
05/10/1995EP0510154B1 9-HALOGEN-11(Beta)-HYDROXY PROSTAGLANDIN DERIVATIVE, PROCESS FOR PRODUCING IT AND ITS USE AS A MEDICAMENT
05/10/1995EP0496835B1 Solid tumor treatment method and composition
05/10/1995CN1102529A Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
05/10/1995CN1102528A Phosphonic diester derivative
05/10/1995CN1102527A Piperazinocarbonylcarbostyrils as peripheral vasodilators
05/10/1995CN1102437A Materials and methods for screening anti-osteoporosis agents
05/10/1995CN1102413A Arteannuin derivant and its composition and application
05/10/1995CN1102324A Pharmaceutical composition
05/10/1995CN1102323A Sustained release compositions and a method of preparing pharmaceutical compositions
05/10/1995CN1028368C Process for preparing nojirimycin derivatives
05/10/1995CN1028367C Nonsaditive antihistaminics derived from benzimidazoles
05/10/1995CN1028362C Deacetylcolchicine derivatives
05/10/1995CN1028361C Glutaric acid derivatives and preparations thereof
05/10/1995CA2135265A1 Stable lyophilized thiotepa composition
05/10/1995CA2135227A1 Method for preventing hair loss and stimulating new hair growth
05/09/1995US5414096 Chemical intermediates; DNA viruses
05/09/1995US5414088 2-bicyclobenzimidazoles, processes for their preparation and medicaments containing these compounds
05/09/1995US5414082 Anticonvulsants
05/09/1995US5414073 Treatment with dimethylphosphoryl azide and hydrolysis
05/09/1995US5414068 Crosslinked anion exchange particles and method for producing the particles
05/09/1995US5414019 Regression of mammalian carcinomas
05/09/1995US5414015 Anti-skin tumor promoting composition
05/09/1995US5414014 Methods for efficacious removal of attached, sucking antropods from human dermis
05/09/1995US5414012 Indalyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/09/1995US5414011 Preservative system for ophthalmic formulations
05/09/1995US5414009 Azabicyclo substituted oxa- or thia-diazole compounds
05/09/1995US5414008 Imidazolyl-substituted phenylpropionic and cinnamic acid derivatives
05/09/1995US5414005 Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
05/09/1995US5414004 Neurotransmitter releasers useful for cognition enhancement
05/09/1995US5414003 Pyridinylmethyl-substituted pyridines and pyridones
05/09/1995US5414002 5- or 6-substituted β-carboline-3-carboxylic acid esters
05/09/1995US5414000 Antiviral pyrinyl substituted tetrahydropyrans
05/09/1995US5413999 HIV protease inhibitors useful for the treatment of AIDS
05/09/1995US5413998 Benzo-fused thiazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/09/1995US5413997 Triphenylmethane derivatives
05/09/1995US5413996 Targeted drug delivery via phosphonate derivatives
05/09/1995US5413995 Mannitol as excipient
05/09/1995US5413994 Some of the amidines as new compounds; use as calcium metabolism regulators
05/09/1995US5413993 Method for the treatment of narcotic withdrawal symptoms in animals using lipopolysaccharides
05/09/1995US5413991 Chitinase inhibitors; fungicides, insecticides
05/09/1995US5413782 Binding pharmaceuticals to ion exchange resins
05/09/1995US5413780 Liquid skin coating or protectant
05/09/1995US5413777 Pulsatile once-a-day delivery systems for minocycline
05/09/1995US5413776 Pharmaceutical preparation for percutaneous absorption
1 ... 7020 7021 7022 7023 7024 7025 7026 7027 7028 7029 7030 7031 7032 7033 7034 7035 7036 7037 7038 7039 7040 ... 7860